EcoDrugPlus

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 8

Ensembl ID : ENSIPUG00000004801
Gene Symbol: ABCC8
3 Cross references
229 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 9

Ensembl ID : ENSIPUG00000006065
Gene Symbol: ABCC9
3 Cross references
234 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Alpha

Ensembl ID : ENSIPUG00000007106
Gene Symbol: LOC108256310
3 Cross references
183 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Beta

Ensembl ID : ENSIPUG00000010519
Gene Symbol: LOC108259063
3 Cross references
184 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1b

Ensembl ID : ENSIPUG00000023616
Gene Symbol: ATP1A1B
3 Cross references
150 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 2a

Ensembl ID : ENSIPUG00000018863
Gene Symbol: ATP1A2A
3 Cross references
205 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1a

Ensembl ID : ENSIPUG00000009526
Gene Symbol: ATP1B1A
2 Cross references
225 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1b

Ensembl ID : ENSIPUG00000009292
Gene Symbol: ATP1B1B
3 Cross references
220 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2a

Ensembl ID : ENSIPUG00000004548
Gene Symbol: ATP1B2A
3 Cross references
204 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2b

Ensembl ID : ENSIPUG00000022165
Gene Symbol: ATP1B2B
4 Cross references
203 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3b

Ensembl ID : ENSIPUG00000020493
Gene Symbol: ATP1B3B
4 Cross references
232 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSIPUG00000015422
Gene Symbol: ATR
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).